Skip to main content
Top

Cardiac Regeneration and Repair in Zebrafish and Mammalian Models

  • Open Access
  • 01-12-2025
  • Regenerative Medicine (SM Wu, Section Editor)
Published in:

Abstract

Aim

In this review, we discuss the regenerative processes in the heart, focusing on non-cardiomyocyte cell populations (fibroblasts, immune cells, and endothelial cells) in zebrafish and mammals. We highlight the role of signaling pathways in heart repair and the potential for therapeutic strategies based on these mechanisms.

Purpose of Review

The review examines key molecular and cellular mechanisms in cardiac regeneration, with a focus on fibroblasts, immune modulation, and endothelial function, to identify strategies for enhancing heart repair.

Recent Findings

Recent advancements in characterization of different cell types at the single cell level, along with the discovery of regeneration enhancer elements, have opened new avenues for cardiac regeneration.

Summary

Targeting the epicardium, along with fibroblast activation, immune modulation, and endothelial signaling, may offer therapeutic strategies to enhance heart regeneration by supporting cardiomyocytes in mice and humans. While non-cardiomyocytes in zebrafish contribute to heart regeneration, in mice and humans, these cells often drive fibrosis instead. Understanding these species-specific differences is crucial for optimizing therapeutic approaches to treat cardiac injury and prevent fibrosis.

Graphical Abstract

Title
Cardiac Regeneration and Repair in Zebrafish and Mammalian Models
Authors
Stanislao Igor Travisano
Ching-Ling Lien
Publication date
01-12-2025
Publisher
Springer US
Published in
Current Cardiology Reports / Issue 1/2025
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-025-02235-6
This content is only visible if you are logged in and have the appropriate permissions.

Other articles of this Issue 1/2025

Childhood Adversity and Cardiovascular Disease; Current Knowledge and Future Directions

  • Psychological Aspects of Cardiovascular Diseases (IM Kronish and JL Birk, Section Editors)

Old and New Biomarkers in Idiopathic Recurrent Acute Pericarditis (IRAP): Prognosis and Outcomes

  • Open Access
  • Biomarkers
  • Pericardial Disease (AL Klein and CL Jellis, Section Editors)

Contemporary Insights into LMNA Cardiomyopathy

Alteration of Essential Cell Function by Ultrasound-Targeted Microbubble Cavitation

  • Echocardiography (JM Gardin and AH Waller, Section Editors)

The Ross Procedure: Historical Context, Modern Outcomes, and the Road Ahead

Venous Insufficiency: Endovascular and Surgical Treatment

  • Open Access
  • Sclerotherapy
  • Peripheral Vascular Disease (S Kinlay, Section Editor)

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME